- Home
- APLS vs OPCH Comparison
APLS vs OPCH Comparison
Compare APLS & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- OPCH
- Stock Information
- Founded
- APLS 2009
- OPCH N/A
- Country
- APLS United States
- OPCH United States
- Employees
- APLS N/A
- OPCH N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- OPCH Medical/Nursing Services
- Sector
- APLS Health Care
- OPCH Health Care
- Exchange
- APLS Nasdaq
- OPCH Nasdaq
- Market Cap
- APLS 4.0B
- OPCH 4.0B
- IPO Year
- APLS 2017
- OPCH N/A
- Fundamental
- Price
- APLS $30.13
- OPCH $29.47
- Analyst Decision
- APLS Buy
- OPCH Buy
- Analyst Count
- APLS 18
- OPCH 6
- Target Price
- APLS $46.71
- OPCH $29.33
- AVG Volume (30 Days)
- APLS 2.1M
- OPCH 2.0M
- Earning Date
- APLS 02-25-2025
- OPCH 02-26-2025
- Dividend Yield
- APLS N/A
- OPCH N/A
- EPS Growth
- APLS N/A
- OPCH N/A
- EPS
- APLS N/A
- OPCH 1.19
- Revenue
- APLS $715,216,000.00
- OPCH $4,776,174,000.00
- Revenue This Year
- APLS $95.82
- OPCH $16.70
- Revenue Next Year
- APLS $12.02
- OPCH $6.29
- P/E Ratio
- APLS N/A
- OPCH $24.52
- Revenue Growth
- APLS 162.10
- OPCH 13.58
- 52 Week Low
- APLS $24.34
- OPCH $21.39
- 52 Week High
- APLS $71.90
- OPCH $34.63
- Technical
- Relative Strength Index (RSI)
- APLS 44.83
- OPCH 80.11
- Support Level
- APLS $27.61
- OPCH $23.50
- Resistance Level
- APLS $30.13
- OPCH $29.52
- Average True Range (ATR)
- APLS 1.50
- OPCH 0.81
- MACD
- APLS -0.35
- OPCH 0.68
- Stochastic Oscillator
- APLS 33.82
- OPCH 99.29
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.